Pfizer Inc. (IPA: /ˈfaɪzər/) è un'azienda farmaceutica statunitense, fondata nel corso della breve presidenza di Zachary Taylor, è la più grande società del mondo operante nel settore della ricerca, della produzione e della commercializzazione di farmaci. 20 minute delayed data provided by Comstock. Charts are provided by BigCharts and MarketWatch, Inc. Pfizer makes no claims concerning the accuracy of the information provided on these pages, and will not be held liable for any use of this information. Angela Hwang is the Group President of the Pfizer Biopharmaceuticals Group and a member of the company's Executive Leadership Team. In this role, she leads all Pfizer's innovative medicines businesses; a global organization that operates in more than 125 countries, with a portfolio of more than 600 products generating approximately three. Clearly this analysis is distorted to some extent by the earlier launch date of Lipitor (in 1996). However, if we look at cumulative sales during the first 10 years of availability, Lipitor still. Last month, business news outlets were reporting that stock prices for pharmaceutical firms Pfizer and Merck took a tumble after financial analysts downgraded the performance of both firms over. Pfizer's patent protection expires April 2020, but Teva will be allowed to launch generic version on Dec. 11, 2017 Pfizer Inc. (/ ˈ f aɪ z ər /) is an American pharmaceutical corporation headquartered in New York City, with its research headquarters in Groton, Connecticut. The Established Medicines business, which will have “substantial autonomy” within Pfizer, will include the majority of Pfizer’s off-patent solid oral-dose legacy brands, including Lyrica, Lipitor, Norvasc and Viagra, and certain generic medicines, the company reported. Atorvastatin, sold under the trade name Lipitor among others, is a statin medication used to prevent cardiovascular disease in those at high risk and treat abnormal lipid levels. For the prevention of cardiovascular disease, statins are a first-line treatment. It is taken by mouth. As trade publication FiercePharma noted, “The AARP report itself is a pretty good playbook for drug makers facing a patent loss.” According to the study, Pfizer’s moves to hang onto Lipitor.